EDIT
Editas Medicine Inc
2.90$
+3.2%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -331.7% | -824.8% | -68.6% | -143.1% | -198.1% | -198.2% | -641.3% | -899.7% | -169.2% | -650.8% | -407.8% | |
| – | 28.9% | 19.9% | 19.5% | 10.2% | 13.8% | 4.4% | 19.8% | 32.1% | 7.8% | 18.0% | 13.0% | |
| – | 215.7% | 278.9% | 170.2% | 83.3% | 132.7% | 25.5% | 169.9% | 148.6% | 25.3% | 66.3% | 24.7% | |
| – | 2,514.9% | 459.9% | 273.6% | 118.3% | 118.4% | 55.9% | 176.4% | 144.9% | – | – | – | |
| – | 3,875.0% | 306.1% | 514.7% | 84.2% | 321.1% | -112.7% | -83.8% | 41.5% | -2.0% | 10.7% | -77.1% | |
| – | 87.8% | 57.7% | 15.0% | 14.9% | 30.0% | 7.9% | 31.2% | 20.9% | 6.0% | 27.3% | 1.5% | |
| – | -87.8% | -84.1% | -1,338.9% | -166.2% | 59.7% | -154.9% | -213.2% | 578.7% | -4.8% | 501.8% | 342.2% | |
| – | 8,790.3% | 12.9% | 0.1% | 0.0% | – | – | – | – | – | – | – | |
| – | 1.0% | 0.2% | 0.1% | 0.0% | 642.1% | 247.0% | 1,104.4% | 6.5% | – | – | – | |
| – | -30.7% | -9.3% | -9.9% | -2.7% | – | – | – | – | – | – | – | |
| – | 8,556.8% | 1,605.2% | 1,125.7% | 272.2% | 642.1% | 247.0% | 1,104.4% | 6.5% | 151.1% | 173.4% | 99.9% | |
| – | 8,137.3% | 696.2% | -281.9% | -37.1% | 503.7% | -106.1% | 249.9% | -314.5% | -22.9% | 24.4% | 34.3% | |
| – | -419.5% | -882.5% | -83.6% | -158.0% | -228.1% | -206.1% | -672.5% | -920.6% | -175.2% | -678.1% | -409.3% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.